Skip to main content
. 2018 Jul 3;9(51):29644–29653. doi: 10.18632/oncotarget.25662

Table 4. The influence of APEH genotypes on the severity of oral mucositis after subsequent weeks of radiotherapy.

RTH week Radiation reaction grade CC (n = 23; %) GG or GC (n = 39; %) p, OR [95% CI] GG (n = 12; %) CC or GC (n = 50; %) p, OR [95% CI] CG (n = 27; %) CC or GG (n = 35; %) p, OR [95% CI]
1 0 (n = 6; 9.7%) 4 (66.67%) 2 (33.33%) 0.1355
0.26 [0.04–1.53]
6 (100.0%) 0.3886
3.65 [0.19–69.36]
2 (33.33%) 4 (66.67%) 0.5981
1.61 [0.27–9.54]
1 (n = 56; 90.3%) 19 (32.20%) 37 (67.80%) 12 (21.43%) 44 (78.57%) 25 (44.64%) 31 (55.36%)
2 1 (n = 36; 58.1%) 16 (44.44%) 20 (55.56%) 0.1624
0.46 [0.15–1.37]
7 (19.44%) 29 (80.56%) 0.9832
0.99 [0.27–3.54]
13 (36.11%) 23 (63.89%) 0.1671
2.06 [0.74–5.77]
2 (n = 26; 41.9%) 7 (26.92%) 19 (73.08%) 5 (19.23%) 21 (80.77%) 14 (53.85%) 12 (33.33%)
3 1 (n = 21; 33.9%) 12 (57.14%) 9 (42.86%) 0.0222
0.27 [0.09–0.83]
3 (14.29%) 18 (185.71%) 0.4728
1.69 [0.40–7.04]
6 (28.57%) 15 (71.43%) 0.0934
2.08 [0.68–6.36]
2 and 3 (n = 41; 66.1%) 11 (26.83%) 30 (73.17%) 9 (21.95%) 32 (78.05%) 21 (51.22%) 20 (48.78%)
1 and 2 (n = 56; 90.3%) 22 (39.29%) 34 (60.71%) 0.2984
0.31 [0.03–2.83]
11 (19.64%) 45 (26.79%) 0.8610
0.82 [0.09–7.73]
23 (41.07%) 33 (58.93%) 0.1810
2.62 [0.85–8.11]
3 (n = 6; 9.7%) 1 (16.67%) 5 (83.33%) 1 (16.67%) 5 (83.33%) 4 (66.67%) 2 (33.33%)
4 1 (n = 11; 17.7%) 8 (72.73%) 3 (27.27%) 0.0125
0.16 [0.04–0.67]
2 (18.18%) 9 (81.82%) 0.9136
1.10 [0.20–5.89]
1 (9.09%) 10 (90.91%) 0.0310
10.40 [1.23–87.31]
2 and 3 (n = 51; 82.3%) 15 (29.41%) 36 (70.59%) 10 (19.60%) 41 (80.40%) 26 (50.98%) 25 (49.02%)
1 and 2 (n = 48; 77.4%) 20 (41.67%) 28 (58.33%) 0.1776
0.38 [0.09–1.55]
7 (14.58%) 41 (85.42%) 0.0880
3.25 [0.84–12.62]
21 (43.75%) 27 (56.25%) 0.9527
0.96 [0.29–3.21]
3 (n = 14; 22.6%) 3 (21.43%) 11 (78.57%) 5 (35.71%) 9 (64.29%) 6 (42.86%) 8 (57.14%)
5 1 (n = 6;9.7%) 4 (66.67%) 2 (33.33%) 0.1355
0.26 [0.04–1.53]
2 (33.33%) 4 (66.67%) 0.3723
0.43 [0.07–2.71]
6 (100.00%) 0.0944
12.12 [0.65–225.38]
2 and 3 (n = 56.;90.3%) 19 (33.93%) 37 (66.07%) 10 (17.86%) 46 (82.14%) 27 (48.21%) 29 (51.79%)
1 and 2 (n = 48;77.4%) 20 (41.67%) 28 (58.33%) 0.1776
0.38 [0.09–1.55]
7 (14.58%) 41 (85.42%) 0.0880
3.25 [0.84–12.62]
21 (43.75%) 27 (56.25%) 0.9527
0.96 [0.29–3.21]
3 (n = 14; 22.6%) 3 (21.43%) 11 (78.57%) 5 (35.71%) 9 (64.29%) 6 (42.86%) 8 (57.14%)
6 1 (n = 6; 9.7%) 4 (66.67%) 2 (33.33%) 0.1355
0.26 [0.04–1.53]
2 (33.33%) 4 (66.67%) 0.3723
0.43 [0.07–2.71]
6 (100.00%) 0.0944
12.12 [0.65–225.38]
2 and 3 (n = 56; 90.3%) 19 (33.93%) 37 (66.07%) 10 (17.86%) 46 (82.14%) 27 (48.21%) 29 (51.79%)
1 and 2 (n = 47; 75.8%) 18 (38.30%) 29 (61.70%) 0.7292
0.81 [0.24–2.74]
10 (21.28%) 37 (78.72%) 0.5018
0.57 [0.11–2.95]
19 (40.43%) 28 (59.57%) 0.3824
1.68 [0.52–5.42]
3 (n = 15; 24.2%) 5 (33.33%) 10 (66.67%) 2 (13.33%) 13 (86.67%) 8 (53.33%) 7 (46.67%)
7 1 (n = 5; 8.1%) 4 (80.00%) 1 (20.00%) 0.0713
0.12 [0.01–1.20]
1 (20.00%) 4 (80.00%) 0.9696
0.96 [0.10–9.43]
5 (100.00%) 0.1262
9.92 [0.52–187.73]
2 and 3 (n = 57; 91.9%) 19 (33.33%) 38 (66.67%) 11 (19.30%) 46 (80.70%) 27 (47.37%) 30 (52.63%)
1 and 2 (n = 36; 58.1%) 18 (50.00%) 18 (50.00%) 0.0166
0.23 [0.07–0.77]
4 (11.11%) 32 (88.89%) 0.0619
3.56 [0.94–13.47]
14 (38.89%) 22 (61.11%) 0.3850
1.57 [0.57–4.36]
3 (n = 26; 41.9%) 5 (19.23%) 21 (80.77%) 8 (30.77%) 18 (69.23%) 13 (50.00%) 13 (50.00%)